Insider Trading › ALKS › Insiders
Alkermes plc.
ALKS·Nasdaq·
Ireland·Insider activity
Ireland·Insider activity$41.65
-1.11 (-2.60%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
ALKS
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ALKSS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, ALKS insiders filed 0 purchases ($0) and 17 sales ($5.9M) on the open market, by 6 insiders. Newest filing Oct 2, 2026 (5 days ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by ALKS insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$5.9MSales · 180 days
1,014Open-market transactions on record
6Insiders filing · 180 days
Purchases (code P) and sales (code S) of ALKS common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
1,014 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Sale | −2,034 | $41.03 | $83K | 221.4Kdirect | Oct 2, 2026 | Oct 2, 2026 | Form 4 ↗ |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Sale | −2,034 | $48.01 | $98K | 223.4Kdirect | Sep 3, 2026 | Sep 3, 2026 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −9,000 | $46.99 | $423K | 65.4Kdirect | Sep 1, 2026 | Sep 1, 2026 | Form 4 ↗ |
| Nichols Christian ToddSVP, Chief Commercial Officer | Sale | −6,912 | $49.19 | $340K | 102.9Kdirect | Aug 17, 2026 | Aug 17, 2026 | Form 4 ↗ |
| Nichols Christian ToddSVP, Chief Commercial Officer | Sale | −664 | $49.65 | $33K | 102.2Kdirect | Aug 17, 2026 | Aug 17, 2026 | Form 4 ↗ |
| snyderman nancy lynn MDDirector · Director | Sale | −44.5K | $50.35 | $2.2M | 15.4Kdirect | Aug 3, 2026 | Aug 3, 2026 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −9,000 | $48.58 | $437K | 69.4Kdirect | Aug 3, 2026 | Aug 3, 2026 | Form 4 ↗ |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Sale | −2,034 | $48.58 | $99K | 225.5Kdirect | Aug 3, 2026 | Aug 3, 2026 | Form 4 ↗ |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Sale | −2,034 | $54.03 | $110K | 227.5Kdirect | Jul 6, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −8,300 | $51.46 | $427K | 74.1Kdirect | Jul 1, 2026 | Jul 1, 2026 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −700 | $52.13 | $36K | 73.4Kdirect | Jul 1, 2026 | Jul 1, 2026 | Form 4 ↗ |
| Wright Christopher IDirector | Sale | −2,000 | $45.10 | $90K | 25.7Kdirect | Jun 12, 2026 | Jun 12, 2026 | Form 4 ↗ |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Sale | −2,034 | $43.05 | $88K | 229.5Kdirect | Jun 4, 2026 | Jun 4, 2026 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −9,000 | $41.67 | $375K | 77.4Kdirect | Jun 1, 2026 | Jun 1, 2026 | Form 4 ↗ |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Sale | −16.2K | $42.36 | $687K | 7,717direct | May 29, 2026 | May 29, 2026 | Form 4 ↗ |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Sale | −2,034 | $33.20 | $68K | 231.6Kdirect | May 4, 2026 | May 4, 2026 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −9,000 | $33.40 | $301K | 81.4Kdirect | May 1, 2026 | May 1, 2026 | Form 4 ↗ |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Sale | −2,034 | $34.57 | $70K | 233.6Kdirect | Apr 6, 2026 | Apr 6, 2026 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −9,000 | $35.51 | $320K | 85.4Kdirect | Apr 1, 2026 | Apr 1, 2026 | Form 4 ↗ |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Sale | −2,034 | $29.76 | $61K | 235.6Kdirect | Mar 3, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Sale | −6,890 | $29.29 | $202K | 7,717direct | Mar 2, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Nichols Christian ToddSVP, Chief Commercial Officer | Sale | −6,000 | $30.00 | $180K | 109.8Kdirect | Mar 2, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −9,000 | $29.72 | $267K | 89.4Kdirect | Mar 2, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Gaffin David JosephEVP, CLO, Alkermes, Inc. | Sale | −2,034 | $29.29 | $60K | 237.7Kdirect | Mar 2, 2026 | Mar 4, 2026 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −4,000 | $33.54 | $134K | 57.7Kdirect | Feb 2, 2026 | Feb 2, 2026 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −5,000 | $34.24 | $171K | 61.7Kdirect | Feb 2, 2026 | Feb 2, 2026 | Form 4 ↗ |
| Cooke ShaneDirector | Sale | −32.1K | $34.78 | $1.1M | 103.7Kdirect | Feb 2, 2026 | Feb 2, 2026 | Form 4 ↗ |
| Cooke ShaneDirector | Sale | −29.1K | $34.34 | $999K | 135.9Kdirect | Feb 2, 2026 | Feb 2, 2026 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −5,000 | $30.00 | $150K | 61.7Kdirect | Jan 8, 2026 | Jan 8, 2026 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −4,000 | $28.00 | $112K | 61.7Kdirect | Jan 2, 2026 | Jan 2, 2026 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −3,748 | $30.00 | $112K | 65.7Kdirect | Dec 3, 2025 | Dec 5, 2025 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −4,000 | $29.30 | $117K | 65.7Kdirect | Dec 1, 2025 | Dec 1, 2025 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −9,000 | $30.38 | $273K | 69.7Kdirect | Nov 3, 2025 | Nov 3, 2025 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −9,000 | $31.53 | $284K | 73.7Kdirect | Oct 15, 2025 | Oct 15, 2025 | Form 4 ↗ |
| Nichols Christian ToddSVP, Chief Commercial Officer | Sale | −3,334 | $31.09 | $104K | 86.2Kdirect | Jun 10, 2025 | Jun 10, 2025 | Form 4 ↗ |
| Nichols Christian ToddSVP, Chief Commercial Officer | Sale | −3,333 | $31.95 | $106K | 89.5Kdirect | Jun 9, 2025 | Jun 10, 2025 | Form 4 ↗ |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Sale | −1,938 | $34.00 | $66K | 7,717direct | Feb 28, 2025 | Feb 28, 2025 | Form 4 ↗ |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Sale | −3,743 | $35.26 | $132K | 7,717direct | Feb 25, 2025 | Feb 25, 2025 | Form 4 ↗ |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Sale | −1,327 | $35.69 | $47K | 7,717direct | Feb 20, 2025 | Feb 20, 2025 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −108.8K | $36.02 | $3.9M | 57.9Kdirect | Feb 13, 2025 | Feb 14, 2025 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −35.6K | $34.02 | $1.2M | 166.7Kdirect | Feb 13, 2025 | Feb 14, 2025 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −33.1K | $33.27 | $1.1M | 57.9Kdirect | Feb 12, 2025 | Feb 14, 2025 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −171.8K | $32.69 | $5.6M | 91.0Kdirect | Feb 12, 2025 | Feb 14, 2025 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −100.9K | $32.05 | $3.2M | 44.3Kdirect | Jan 30, 2025 | Jan 31, 2025 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −61.2K | $32.07 | $2.0M | 47.6Kdirect | Dec 9, 2024 | Dec 9, 2024 | Form 4 ↗ |
| LAURENCIN CATO TDirector | Sale | −2,691 | $31.85 | $86K | 23.0Kdirect | Dec 9, 2024 | Dec 9, 2024 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −9,221 | $31.50 | $290K | 59.7Kdirect | Dec 5, 2024 | Dec 5, 2024 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −14.3K | $30.77 | $442K | 69.0Kdirect | Dec 4, 2024 | Dec 4, 2024 | Form 4 ↗ |
| Nichols Christian ToddSVP, Chief Commercial Officer | Sale | −5,208 | $29.15 | $152K | 60.7Kdirect | Nov 27, 2024 | Nov 27, 2024 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −59.0K | $30.08 | $1.8M | 83.3Kdirect | Nov 11, 2024 | Nov 12, 2024 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −10.5K | $29.53 | $309K | 99.2Kdirect | Nov 6, 2024 | Nov 6, 2024 | Form 4 ↗ |
| Nichols Christian ToddSVP, Chief Commercial Officer | Sale | −10.4K | $28.10 | $293K | 65.9Kdirect | Mar 18, 2024 | Mar 18, 2024 | Form 4 ↗ |
| Parisi Samuel JosephVP, Finance (Interim PAO) | Sale | −2,559 | $29.65 | $76K | 7,717direct | Feb 27, 2024 | Feb 27, 2024 | Form 4 ↗ |
| LAURENCIN CATO TDirector | Sale | −2,690 | $31.85 | $86K | 15.2Kdirect | Feb 15, 2024 | Feb 16, 2024 | Form 4 ↗ |
| LAURENCIN CATO TDirector | Sale | −2,638 | $31.85 | $84K | 7,479direct | Jun 8, 2023 | Jun 8, 2023 | Form 4 ↗ |
| LAURENCIN CATO TDirector | Sale | −2,800 | $31.50 | $88K | 7,479direct | Jun 7, 2023 | Jun 7, 2023 | Form 4 ↗ |
| Nichols Christian ToddSVP, Chief Commercial Officer | Sale | −27.1K | $28.93 | $785K | 41.0Kdirect | May 30, 2023 | May 30, 2023 | Form 4 ↗ |
| Wysenski NancyDirector | Sale | −41.3K | $31.24 | $1.3M | 15.8Kdirect | May 9, 2023 | May 10, 2023 | Form 4 ↗ |
| Daglio David Angelo Jr.Director | Purchase | +35.0K | $23.31 | $816K | 80.0Kindirect | Nov 14, 2022 | Nov 16, 2022 | Form 4 ↗ |
| Nichols Christian ToddSVP, Chief Commercial Officer | Sale | −7,474 | $28.26 | $211K | 21.0Kdirect | Jun 21, 2022 | Jun 21, 2022 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −50.0K | $29.15 | $1.5M | 232.3Kdirect | May 17, 2022 | May 19, 2022 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −25.0K | $27.22 | $681K | 232.3Kdirect | May 10, 2022 | May 12, 2022 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −93.7K | $27.85 | $2.6M | 968.3Kdirect | May 6, 2022 | May 6, 2022 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −32.3K | $28.59 | $923K | 941.2Kdirect | May 5, 2022 | May 6, 2022 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −221.2K | $27.95 | $6.2M | 973.5Kdirect | May 5, 2022 | May 6, 2022 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −25.0K | $28.62 | $716K | 232.3Kdirect | May 3, 2022 | May 3, 2022 | Form 4 ↗ |
| Cooke ShaneDirector | Sale | −10.0K | $29.23 | $292K | 90.5Kdirect | May 2, 2022 | May 3, 2022 | Form 4 ↗ |
| Cooke ShaneDirector | Sale | −10.0K | $27.88 | $279K | 90.5Kdirect | Apr 25, 2022 | Apr 27, 2022 | Form 4 ↗ |
| Jackson Blair CurtisEVP, Chief Operating Officer | Sale | −50.0K | $29.61 | $1.5M | 87.9Kdirect | Apr 20, 2022 | Apr 22, 2022 | Form 4 ↗ |
| Cooke ShaneDirector | Sale | −10.0K | $28.88 | $289K | 90.5Kdirect | Apr 18, 2022 | Apr 19, 2022 | Form 4 ↗ |
| Cooke ShaneDirector | Sale | −10.0K | $29.26 | $293K | 90.5Kdirect | Apr 11, 2022 | Apr 12, 2022 | Form 4 ↗ |
| Cooke ShaneDirector | Sale | −10.0K | $28.18 | $282K | 90.5Kdirect | Apr 4, 2022 | Apr 5, 2022 | Form 4 ↗ |
| snyderman nancy lynn MDDirector | Purchase | +427 | $23.43 | $10K | 9,366direct | Mar 4, 2022 | Mar 8, 2022 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −12.0K | $24.76 | $297K | 18.0Kdirect | Feb 23, 2022 | Feb 24, 2022 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −2,306 | $25.17 | $58K | 9,496direct | Feb 18, 2022 | Feb 23, 2022 | Form 4 ↗ |
| Alva Emily PetersonDirector | Purchase | +1,650 | $30.22 | $50K | 1,650direct | Aug 23, 2021 | Aug 24, 2021 | Form 4 ↗ |
| Brown Iain MichaelSVP, Chief Financial Officer | Sale | −40.0K | $29.99 | $1.2M | 43.0Kdirect | Aug 19, 2021 | Aug 20, 2021 | Form 4 ↗ |
| MCKEON BRIAN PDirector | Purchase | +10.0K | $26.43 | $264K | 10.0Kindirect | Aug 2, 2021 | Aug 4, 2021 | Form 4 ↗ |
| Gaffin David JosephSVP, CLO, Alkermes, Inc. | Sale | −14.0K | $26.00 | $364K | 74.6Kdirect | Jul 29, 2021 | Jul 30, 2021 | Form 4 ↗ |
| ANSTICE DAVID WDirector | Sale | −20.0K | $24.58 | $492K | 73.1Kdirect | Jul 1, 2021 | Jul 2, 2021 | Form 4 ↗ |
| Gaffin David JosephSVP, CLO, Alkermes, Inc. | Sale | −13.5K | $25.00 | $338K | 74.6Kdirect | Jun 10, 2021 | Jun 11, 2021 | Form 4 ↗ |
| DIXON WENDY LDirector | Sale | −25.0K | $25.00 | $625K | 41.3Kdirect | Jun 10, 2021 | Jun 11, 2021 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −882 | $24.60 | $22K | 0direct | Jun 9, 2021 | Jun 11, 2021 | Form 4 ↗ |
| Gaffin David JosephSVP, CLO, Alkermes, Inc. | Sale | −13.5K | $24.00 | $324K | 74.6Kdirect | Jun 7, 2021 | Jun 8, 2021 | Form 4 ↗ |
| ANSTICE DAVID WDirector | Sale | −5,000 | $24.00 | $120K | 73.1Kdirect | Jun 7, 2021 | Jun 8, 2021 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −150.0K | $21.90 | $3.3M | 792.0Kdirect | May 18, 2021 | May 19, 2021 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −50.0K | $22.09 | $1.1M | 216.8Kdirect | May 17, 2021 | May 19, 2021 | Form 4 ↗ |
| Gaffin David JosephSVP, CLO, Alkermes, Inc. | Sale | −2,250 | $22.23 | $50K | 74.6Kdirect | May 14, 2021 | May 14, 2021 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −25.0K | $22.39 | $560K | 216.8Kdirect | May 13, 2021 | May 14, 2021 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −60.3K | $22.30 | $1.3M | 792.0Kdirect | May 11, 2021 | May 12, 2021 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −89.7K | $21.95 | $2.0M | 852.3Kdirect | May 11, 2021 | May 12, 2021 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −19.5K | $22.10 | $430K | 216.8Kdirect | May 7, 2021 | May 7, 2021 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −100.0K | $21.79 | $2.2M | 792.0Kdirect | May 6, 2021 | May 7, 2021 | Form 4 ↗ |
| Jackson Blair CurtisEVP, Chief Operating Officer | Sale | −34.5K | $22.18 | $765K | 68.2Kdirect | May 3, 2021 | May 4, 2021 | Form 4 ↗ |
| DIXON WENDY LDirector | Sale | −25.0K | $20.00 | $500K | 36.6Kdirect | Apr 19, 2021 | Apr 20, 2021 | Form 4 ↗ |
| Brown Iain MichaelSVP, Chief Financial Officer | Sale | −34.8K | $20.00 | $696K | 48.4Kdirect | Apr 19, 2021 | Apr 20, 2021 | Form 4 ↗ |
| Brown Iain MichaelSVP, Chief Financial Officer | Sale | −208 | $19.99 | $4K | 48.4Kdirect | Apr 16, 2021 | Apr 20, 2021 | Form 4 ↗ |
| Hopkinson Craig C.EVP R&D, Chief Medical Officer | Sale | −28.9K | $19.72 | $570K | 0direct | Apr 15, 2021 | Apr 16, 2021 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −20.0K | $16.61 | $332K | 7,000indirect | Oct 1, 2020 | Oct 2, 2020 | Form 4 ↗ |
| ANSTICE DAVID WDirector | Sale | −17.8K | $16.79 | $299K | 68.4Kdirect | Sep 28, 2020 | Oct 5, 2020 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −75.0K | $15.00 | $1.1M | 759.1Kdirect | May 14, 2020 | May 14, 2020 | Form 4 ↗ |
| Brown Iain MichaelSVP Finance & CAO, Alks Inc. | Sale | −6,250 | $15.39 | $96K | 38.6Kdirect | May 13, 2020 | May 14, 2020 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −18.0K | $15.75 | $284K | 201.8Kdirect | May 12, 2020 | May 14, 2020 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −50.0K | $14.63 | $732K | 759.1Kdirect | May 7, 2020 | May 7, 2020 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −25.0K | $14.06 | $352K | 201.8Kdirect | May 5, 2020 | May 7, 2020 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −50.0K | $13.79 | $690K | 759.1Kdirect | Apr 2, 2020 | Apr 3, 2020 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −75.0K | $14.36 | $1.1M | 759.1Kdirect | Mar 26, 2020 | Mar 26, 2020 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −25.0K | $13.91 | $348K | 201.8Kdirect | Mar 24, 2020 | Mar 26, 2020 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −16.0K | $15.04 | $240K | 759.1Kdirect | Mar 19, 2020 | Mar 19, 2020 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −48.7K | $14.51 | $706K | 775.1Kdirect | Mar 19, 2020 | Mar 19, 2020 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −10.3K | $13.42 | $139K | 823.7Kdirect | Mar 19, 2020 | Mar 19, 2020 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −2,700 | $14.26 | $39K | 201.8Kdirect | Mar 17, 2020 | Mar 19, 2020 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −22.3K | $13.45 | $300K | 204.5Kdirect | Mar 17, 2020 | Mar 19, 2020 | Form 4 ↗ |
| Wysenski NancyDirector | Purchase | +6,940 | $19.65 | $136K | 11.2Kindirect | Feb 24, 2020 | Feb 25, 2020 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −100.0K | $19.50 | $1.9M | 716.4Kdirect | Nov 14, 2019 | Nov 15, 2019 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −20.0K | $19.70 | $394K | 185.1Kdirect | Nov 13, 2019 | Nov 15, 2019 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −30.2K | $19.73 | $596K | 716.4Kdirect | Nov 8, 2019 | Nov 8, 2019 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −69.8K | $19.81 | $1.4M | 716.4Kdirect | Nov 7, 2019 | Nov 8, 2019 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −20.0K | $19.76 | $395K | 185.1Kdirect | Nov 6, 2019 | Nov 8, 2019 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −100.0K | $21.54 | $2.2M | 716.4Kdirect | Sep 19, 2019 | Sep 23, 2019 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −100.0K | $22.68 | $2.3M | 716.4Kdirect | Sep 12, 2019 | Sep 13, 2019 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −100.0K | $20.18 | $2.0M | 716.4Kdirect | Sep 5, 2019 | Sep 6, 2019 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −50.0K | $24.22 | $1.2M | 716.4Kdirect | May 23, 2019 | May 24, 2019 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −20.0K | $24.93 | $499K | 185.1Kdirect | May 22, 2019 | May 23, 2019 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −60.0K | $25.42 | $1.5M | 716.4Kdirect | May 16, 2019 | May 24, 2019 | Form 4 ↗ |
| Gaffin David JosephSVP, CLO, Alkermes, Inc. | Sale | −3,120 | $27.00 | $84K | 48.5Kdirect | May 9, 2019 | May 13, 2019 | Form 4 ↗ |
| Gaffin David JosephSVP, CLO, Alkermes, Inc. | Sale | −2,253 | $26.75 | $60K | 51.7Kdirect | May 9, 2019 | May 13, 2019 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $36.64 | $37K | 0indirect | Apr 1, 2019 | Apr 2, 2019 | Form 4 ↗ |
| Wysenski NancyDirector | Purchase | +445 | $33.06 | $15K | 4,302indirect | Mar 14, 2019 | Mar 18, 2019 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −25.0K | $33.05 | $826K | 185.1Kdirect | Mar 14, 2019 | Mar 14, 2019 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −15.8K | $33.51 | $530K | 716.4Kdirect | Mar 13, 2019 | Mar 14, 2019 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −44.2K | $33.24 | $1.5M | 716.4Kdirect | Mar 12, 2019 | Mar 14, 2019 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −20.0K | $32.07 | $641K | 185.1Kdirect | Mar 7, 2019 | Mar 7, 2019 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −50.0K | $33.63 | $1.7M | 716.4Kdirect | Mar 5, 2019 | Mar 7, 2019 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $33.48 | $33K | 0indirect | Mar 1, 2019 | Mar 4, 2019 | Form 4 ↗ |
| Wysenski NancyDirector | Purchase | +3,857 | $33.09 | $128K | 3,857indirect | Feb 21, 2019 | Mar 18, 2019 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $32.73 | $33K | 0indirect | Feb 1, 2019 | Feb 1, 2019 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $30.00 | $30K | 0indirect | Jan 4, 2019 | Jan 4, 2019 | Form 4 ↗ |
| ANSTICE DAVID WDirector | Sale | −5,000 | $35.56 | $178K | 66.2Kdirect | Dec 12, 2018 | Dec 13, 2018 | Form 4 ↗ |
| ANSTICE DAVID WDirector | Sale | −235 | $35.92 | $8K | 66.2Kdirect | Dec 12, 2018 | Dec 13, 2018 | Form 4 ↗ |
| ANSTICE DAVID WDirector | Sale | −3,552 | $35.61 | $126K | 66.4Kdirect | Dec 12, 2018 | Dec 13, 2018 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $36.45 | $36K | 0indirect | Dec 3, 2018 | Dec 6, 2018 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $37.51 | $38K | 0indirect | Nov 2, 2018 | Nov 2, 2018 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $42.42 | $42K | 0indirect | Oct 1, 2018 | Oct 2, 2018 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $44.58 | $45K | 0indirect | Sep 4, 2018 | Sep 5, 2018 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $43.68 | $44K | 0indirect | Aug 1, 2018 | Aug 3, 2018 | Form 4 ↗ |
| BLOOM FLOYD EDirector | Sale | −20.0K | $43.95 | $879K | 127.9Kindirect | Jul 16, 2018 | Jul 18, 2018 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $41.86 | $42K | 0indirect | Jul 3, 2018 | Jul 3, 2018 | Form 4 ↗ |
| FRATES JAMES MSVP, Alks Inc; CFO ALKS | Sale | −16.8K | $50.00 | $842K | 37.2Kdirect | Jun 12, 2018 | Jun 13, 2018 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $47.34 | $47K | 0indirect | Jun 1, 2018 | Jun 4, 2018 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −20.0K | $45.22 | $904K | 172.6Kdirect | May 24, 2018 | May 24, 2018 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −3,682 | $46.03 | $169K | 666.4Kdirect | May 22, 2018 | May 24, 2018 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −16.3K | $45.33 | $740K | 670.0Kdirect | May 22, 2018 | May 24, 2018 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −3,100 | $47.15 | $146K | 172.6Kdirect | May 17, 2018 | May 17, 2018 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −16.9K | $45.96 | $777K | 175.7Kdirect | May 17, 2018 | May 17, 2018 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −50.0K | $46.38 | $2.3M | 666.4Kdirect | May 15, 2018 | May 17, 2018 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −7,360 | $44.55 | $328K | 666.4Kdirect | May 8, 2018 | May 10, 2018 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −42.6K | $44.28 | $1.9M | 673.7Kdirect | May 8, 2018 | May 10, 2018 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $44.32 | $44K | 0indirect | May 1, 2018 | May 3, 2018 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −900 | $44.66 | $40K | 666.4Kdirect | May 1, 2018 | May 3, 2018 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −49.1K | $44.01 | $2.2M | 667.3Kdirect | May 1, 2018 | May 3, 2018 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $46.75 | $47K | 0indirect | Apr 2, 2018 | Apr 4, 2018 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $57.04 | $57K | 8,000direct | Mar 1, 2018 | Mar 5, 2018 | Form 4 ↗ |
| Stejbach MarkSVP/Chief Comm Off, Alks Inc | Sale | −10.9K | $70.50 | $767K | 44.0Kdirect | Feb 16, 2018 | Feb 21, 2018 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −19.5K | $61.03 | $1.2M | 74.7Kdirect | Feb 2, 2018 | Feb 2, 2018 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −53.3K | $60.38 | $3.2M | 94.2Kdirect | Feb 2, 2018 | Feb 2, 2018 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $56.77 | $57K | 8,000direct | Feb 1, 2018 | Feb 2, 2018 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −3,300 | $60.00 | $198K | 74.7Kdirect | Jan 29, 2018 | Jan 29, 2018 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −1,700 | $60.02 | $102K | 74.7Kdirect | Jan 26, 2018 | Jan 29, 2018 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −6,207 | $60.22 | $374K | 74.7Kdirect | Jan 11, 2018 | Jan 16, 2018 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $54.99 | $55K | 8,000direct | Jan 2, 2018 | Jan 3, 2018 | Form 4 ↗ |
| Brown Iain MichaelSVP Finance & CAO, Alks Inc. | Sale | −10.7K | $54.81 | $584K | 16.9Kdirect | Dec 29, 2017 | Jan 2, 2018 | Form 4 ↗ |
| KEATING LAURIESVP, GC & Secretary | Sale | −300 | n/c | — | 11.5Kdirect | Dec 20, 2017 | Dec 21, 2017 | Form 4 ↗ |
| KEATING LAURIESVP, GC & Secretary | Sale | −1,900 | n/c | — | 11.8Kdirect | Dec 20, 2017 | Dec 21, 2017 | Form 4 ↗ |
| KEATING LAURIESVP, GC & Secretary | Sale | −4,049 | n/c | — | 13.7Kdirect | Dec 20, 2017 | Dec 21, 2017 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $51.98 | $52K | 8,000direct | Dec 1, 2017 | Dec 1, 2017 | Form 4 ↗ |
| FRATES JAMES MSVP, Alks Inc; CFO ALKS | Sale | −400 | $51.25 | $21K | 144.0Kdirect | Nov 29, 2017 | Nov 30, 2017 | Form 4 ↗ |
| FRATES JAMES MSVP, Alks Inc; CFO ALKS | Sale | −20.5K | $50.49 | $1.0M | 144.4Kdirect | Nov 29, 2017 | Nov 30, 2017 | Form 4 ↗ |
| FRATES JAMES MSVP, Alks Inc; CFO ALKS | Sale | −20.9K | $47.58 | $996K | 144.0Kdirect | Nov 8, 2017 | Nov 9, 2017 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −50.0K | $48.87 | $2.4M | 637.7Kdirect | Nov 2, 2017 | Nov 3, 2017 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,000 | $49.16 | $49K | 8,000direct | Nov 1, 2017 | Nov 3, 2017 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −15.0K | $48.71 | $731K | 163.7Kdirect | Nov 1, 2017 | Nov 3, 2017 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,500 | $50.64 | $76K | 8,000direct | Oct 2, 2017 | Oct 4, 2017 | Form 4 ↗ |
| BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS | Sale | −2,499 | $51.77 | $129K | 56.9Kdirect | Sep 11, 2017 | Sep 13, 2017 | Form 4 ↗ |
| BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS | Sale | −11.1K | $51.18 | $566K | 59.4Kdirect | Sep 11, 2017 | Sep 13, 2017 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,500 | $50.77 | $76K | 8,000direct | Sep 1, 2017 | Sep 5, 2017 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,500 | $54.91 | $82K | 8,000direct | Aug 1, 2017 | Aug 1, 2017 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,500 | $58.11 | $87K | 8,000direct | Jul 3, 2017 | Jul 6, 2017 | Form 4 ↗ |
| Stejbach MarkSVP/Chief Comm Off, Alks Inc | Sale | −10.0K | $60.34 | $603K | 44.0Kdirect | Jun 8, 2017 | Jun 8, 2017 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −10.0K | $60.33 | $603K | 74.7Kdirect | Jun 8, 2017 | Jun 8, 2017 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,500 | $57.49 | $86K | 8,000direct | Jun 1, 2017 | Jun 1, 2017 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −25.0K | $57.42 | $1.4M | 630.4Kdirect | May 24, 2017 | May 25, 2017 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −1,300 | $57.81 | $75K | 162.4Kdirect | May 18, 2017 | May 19, 2017 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −8,700 | $57.14 | $497K | 163.7Kdirect | May 18, 2017 | May 19, 2017 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −5,939 | $59.06 | $351K | 630.4Kdirect | May 17, 2017 | May 19, 2017 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −32.4K | $58.37 | $1.9M | 636.3Kdirect | May 17, 2017 | May 19, 2017 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −11.7K | $57.23 | $667K | 668.8Kdirect | May 17, 2017 | May 19, 2017 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −10.0K | $57.01 | $570K | 162.4Kdirect | May 11, 2017 | May 11, 2017 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −7,841 | $57.67 | $452K | 630.4Kdirect | May 10, 2017 | May 11, 2017 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −17.2K | $57.12 | $980K | 638.2Kdirect | May 10, 2017 | May 11, 2017 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −6,500 | $60.05 | $390K | 71.9Kdirect | May 4, 2017 | May 4, 2017 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −3,500 | $60.05 | $210K | 71.9Kdirect | May 1, 2017 | May 3, 2017 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,500 | $58.74 | $88K | 8,000direct | May 1, 2017 | May 3, 2017 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −10.0K | $56.60 | $566K | 55.1Kdirect | Apr 17, 2017 | Apr 18, 2017 | Form 4 ↗ |
| BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS | Sale | −300 | $59.13 | $18K | 54.9Kdirect | Apr 3, 2017 | Apr 4, 2017 | Form 4 ↗ |
| BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS | Sale | −3,763 | $58.35 | $220K | 55.2Kdirect | Apr 3, 2017 | Apr 4, 2017 | Form 4 ↗ |
| BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS | Sale | −10.9K | $57.41 | $628K | 59.0Kdirect | Apr 3, 2017 | Apr 4, 2017 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,500 | $58.31 | $87K | 8,000direct | Apr 3, 2017 | Apr 4, 2017 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −2,070 | $60.00 | $124K | 71.9Kdirect | Mar 29, 2017 | Mar 29, 2017 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −6,030 | $60.01 | $362K | 71.9Kdirect | Mar 23, 2017 | Mar 27, 2017 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −1,600 | $60.10 | $96K | 71.9Kdirect | Mar 21, 2017 | Mar 22, 2017 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −300 | $60.00 | $18K | 71.9Kdirect | Mar 20, 2017 | Mar 22, 2017 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −6,900 | $57.00 | $393K | 55.1Kdirect | Mar 15, 2017 | Mar 16, 2017 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −4,100 | $56.29 | $231K | 62.0Kdirect | Mar 15, 2017 | Mar 16, 2017 | Form 4 ↗ |
| FRATES JAMES MSVP, Alks Inc; CFO ALKS | Sale | −400 | $59.57 | $24K | 119.1Kdirect | Mar 7, 2017 | Mar 7, 2017 | Form 4 ↗ |
| FRATES JAMES MSVP, Alks Inc; CFO ALKS | Sale | −24.6K | $59.07 | $1.5M | 119.5Kdirect | Mar 7, 2017 | Mar 7, 2017 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −20.0K | $60.00 | $1.2M | 69.4Kdirect | Mar 2, 2017 | Mar 2, 2017 | Form 4 ↗ |
| BREYER ROBERT ADirector | Sale | −4,000 | $60.00 | $240K | 7,156direct | Mar 2, 2017 | Mar 2, 2017 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,500 | $57.06 | $86K | 8,000direct | Mar 1, 2017 | Mar 2, 2017 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −6,085 | $56.84 | $346K | 49.7Kdirect | Feb 16, 2017 | Feb 16, 2017 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −3,915 | $56.05 | $219K | 55.7Kdirect | Feb 16, 2017 | Feb 16, 2017 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −1,000 | $58.17 | $58K | 49.7Kdirect | Feb 15, 2017 | Feb 16, 2017 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,500 | $54.45 | $82K | 8,000direct | Feb 1, 2017 | Feb 2, 2017 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −12.0K | $54.32 | $651K | 50.7Kdirect | Jan 17, 2017 | Jan 18, 2017 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −550 | $60.27 | $33K | 63.9Kdirect | Jan 9, 2017 | Jan 10, 2017 | Form 4 ↗ |
| Stejbach MarkSVP/Chief Comm Off, Alks Inc | Sale | −547 | $60.27 | $33K | 34.1Kdirect | Jan 9, 2017 | Jan 10, 2017 | Form 4 ↗ |
| Stejbach MarkSVP/Chief Comm Off, Alks Inc | Sale | −6,653 | $60.07 | $400K | 34.1Kdirect | Jan 6, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −6,607 | $60.07 | $397K | 63.9Kdirect | Jan 6, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −2,100 | $60.12 | $126K | 52.6Kdirect | Jan 6, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Stejbach MarkSVP/Chief Comm Off, Alks Inc | Sale | −300 | $60.09 | $18K | 34.1Kdirect | Jan 5, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −300 | $60.10 | $18K | 63.9Kdirect | Jan 5, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −400 | $60.08 | $24K | 52.6Kdirect | Jan 5, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Stejbach MarkSVP/Chief Comm Off, Alks Inc | Sale | −2,500 | $60.01 | $150K | 34.1Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Cooke ShanePresident, Alkermes plc | Sale | −2,543 | $60.01 | $153K | 63.9Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −2,500 | $60.01 | $150K | 52.6Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −5,000 | $58.83 | $294K | 55.1Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| BREYER ROBERT ADirector | Sale | −4,000 | $60.00 | $240K | 11.2Kdirect | Jan 4, 2017 | Jan 6, 2017 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,500 | $55.40 | $83K | 8,000direct | Jan 3, 2017 | Jan 4, 2017 | Form 4 ↗ |
| Gaffin David JosephSVP, CLO, Alkermes, Inc. | Sale | −2,500 | $55.40 | $139K | 25.0Kdirect | Jan 3, 2017 | Jan 4, 2017 | Form 4 ↗ |
| Pugh Gordon GSVP, COO & CRO, Alkermes, Inc. | Sale | −4,768 | $57.73 | $275K | 20.6Kdirect | Dec 16, 2016 | Dec 19, 2016 | Form 4 ↗ |
| Pugh Gordon GSVP, COO & CRO, Alkermes, Inc. | Sale | −16.7K | $57.62 | $962K | 20.6Kdirect | Dec 15, 2016 | Dec 19, 2016 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −5,000 | $55.99 | $280K | 52.6Kdirect | Dec 15, 2016 | Dec 15, 2016 | Form 4 ↗ |
| FRATES JAMES MSVP, Alks Inc; CFO ALKS | Sale | −100 | $55.20 | $6K | 112.3Kdirect | Dec 14, 2016 | Dec 15, 2016 | Form 4 ↗ |
| FRATES JAMES MSVP, Alks Inc; CFO ALKS | Sale | −24.9K | $54.72 | $1.4M | 112.4Kdirect | Dec 14, 2016 | Dec 15, 2016 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −17.0K | $55.15 | $937K | 52.6Kdirect | Dec 12, 2016 | Dec 13, 2016 | Form 4 ↗ |
| BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS | Sale | −4,145 | $55.42 | $230K | 38.7Kdirect | Dec 8, 2016 | Dec 8, 2016 | Form 4 ↗ |
| FRATES JAMES MSVP, Alks Inc; CFO ALKS | Sale | −856 | $57.22 | $49K | 112.3Kdirect | Dec 7, 2016 | Dec 8, 2016 | Form 4 ↗ |
| FRATES JAMES MSVP, Alks Inc; CFO ALKS | Sale | −17.4K | $56.44 | $981K | 113.2Kdirect | Dec 7, 2016 | Dec 8, 2016 | Form 4 ↗ |
| FRATES JAMES MSVP, Alks Inc; CFO ALKS | Sale | −5,496 | $55.65 | $306K | 130.6Kdirect | Dec 7, 2016 | Dec 8, 2016 | Form 4 ↗ |
| BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS | Sale | −900 | $57.11 | $51K | 38.7Kdirect | Dec 7, 2016 | Dec 8, 2016 | Form 4 ↗ |
| BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS | Sale | −4,100 | $56.50 | $232K | 39.6Kdirect | Dec 7, 2016 | Dec 8, 2016 | Form 4 ↗ |
| BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS | Sale | −5,000 | $56.24 | $281K | 38.7Kdirect | Dec 6, 2016 | Dec 8, 2016 | Form 4 ↗ |
| BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS | Sale | −7,067 | $56.63 | $400K | 38.7Kdirect | Dec 1, 2016 | Dec 2, 2016 | Form 4 ↗ |
| BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS | Sale | −7,933 | $55.69 | $442K | 45.8Kdirect | Dec 1, 2016 | Dec 2, 2016 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −1,500 | $58.51 | $88K | 155.7Kdirect | Nov 30, 2016 | Nov 30, 2016 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −8,500 | $57.33 | $487K | 157.2Kdirect | Nov 30, 2016 | Nov 30, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −2,050 | $57.72 | $118K | 609.0Kdirect | Nov 29, 2016 | Nov 30, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −27.9K | $56.93 | $1.6M | 611.0Kdirect | Nov 29, 2016 | Nov 30, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −6,885 | $59.44 | $409K | 609.0Kdirect | Nov 22, 2016 | Nov 22, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −23.1K | $58.43 | $1.4M | 615.8Kdirect | Nov 22, 2016 | Nov 22, 2016 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −400 | $59.12 | $24K | 155.7Kdirect | Nov 16, 2016 | Nov 17, 2016 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −9,600 | $58.57 | $562K | 156.1Kdirect | Nov 16, 2016 | Nov 17, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −2,060 | $59.29 | $122K | 609.0Kdirect | Nov 15, 2016 | Nov 17, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −27.9K | $58.78 | $1.6M | 611.0Kdirect | Nov 15, 2016 | Nov 17, 2016 | Form 4 ↗ |
| BREYER ROBERT ADirector | Sale | −20.0K | $60.00 | $1.2M | 15.2Kdirect | Nov 10, 2016 | Nov 14, 2016 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −2,870 | $56.89 | $163K | 155.7Kdirect | Nov 9, 2016 | Nov 10, 2016 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −5,130 | $56.24 | $289K | 158.5Kdirect | Nov 9, 2016 | Nov 10, 2016 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −2,000 | $55.19 | $110K | 163.7Kdirect | Nov 9, 2016 | Nov 10, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −8,946 | $53.82 | $481K | 609.0Kdirect | Nov 8, 2016 | Nov 10, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −21.1K | $53.05 | $1.1M | 617.9Kdirect | Nov 8, 2016 | Nov 10, 2016 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −2,000 | $47.42 | $95K | 8,000direct | Oct 4, 2016 | Oct 4, 2016 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −3,834 | $50.84 | $195K | 45.3Kdirect | Sep 22, 2016 | Sep 22, 2016 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −1,166 | $50.81 | $59K | 45.3Kdirect | Sep 21, 2016 | Sep 22, 2016 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −5,000 | $48.87 | $244K | 45.3Kdirect | Sep 16, 2016 | Sep 19, 2016 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −2,500 | $46.31 | $116K | 45.3Kdirect | Sep 6, 2016 | Sep 7, 2016 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −7,500 | $45.93 | $344K | 47.8Kdirect | Sep 6, 2016 | Sep 7, 2016 | Form 4 ↗ |
| Brown Iain MichaelSVP Finance & CAO, Alks Inc. | Sale | −3,469 | $46.36 | $161K | 22.2Kdirect | Sep 6, 2016 | Sep 7, 2016 | Form 4 ↗ |
| Brown Iain MichaelSVP Finance & CAO, Alks Inc. | Sale | −26.5K | $45.87 | $1.2M | 25.7Kdirect | Sep 6, 2016 | Sep 7, 2016 | Form 4 ↗ |
| Gaffin David JosephSVP, CLO, Alkermes, Inc. | Sale | −2,382 | $45.92 | $109K | 20.4Kdirect | Sep 6, 2016 | Sep 7, 2016 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −400 | $46.28 | $19K | 8,000direct | Sep 6, 2016 | Sep 7, 2016 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −1,600 | $45.83 | $73K | 8,400direct | Sep 6, 2016 | Sep 7, 2016 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −2,000 | $49.48 | $99K | 8,000direct | Aug 4, 2016 | Aug 5, 2016 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −34.4K | $51.95 | $1.8M | 45.3Kdirect | Jul 27, 2016 | Jul 28, 2016 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −800 | $51.82 | $41K | 45.3Kdirect | Jul 26, 2016 | Jul 28, 2016 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −2,000 | $45.81 | $92K | 8,000direct | Jul 5, 2016 | Jul 6, 2016 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −2,000 | $44.98 | $90K | 8,000direct | Jun 6, 2016 | Jun 7, 2016 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −2,000 | $38.60 | $77K | 8,000direct | May 4, 2016 | May 5, 2016 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −6,882 | $41.26 | $284K | 146.8Kdirect | Apr 20, 2016 | Apr 20, 2016 | Form 4 ↗ |
| LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc. | Sale | −9,993 | $40.97 | $409K | 153.6Kdirect | Apr 20, 2016 | Apr 20, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −18.8K | $40.15 | $753K | 576.5Kdirect | Apr 19, 2016 | Apr 20, 2016 | Form 4 ↗ |
| Brown Iain MichaelVP Finance & CAO, Alkermes Inc | Sale | −5,368 | $39.27 | $211K | 46.5Kdirect | Apr 18, 2016 | Apr 20, 2016 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −500 | $38.44 | $19K | 40.9Kdirect | Apr 13, 2016 | Apr 13, 2016 | Form 4 ↗ |
| Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc. | Sale | −11.2K | $37.63 | $421K | 41.4Kdirect | Apr 13, 2016 | Apr 13, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −1,700 | $38.24 | $65K | 576.5Kdirect | Apr 12, 2016 | Apr 13, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −23.3K | $37.76 | $880K | 578.2Kdirect | Apr 12, 2016 | Apr 13, 2016 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −2,000 | $35.65 | $71K | 8,000direct | Apr 4, 2016 | Apr 5, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −15.0K | $32.05 | $481K | 576.5Kdirect | Mar 22, 2016 | Mar 23, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −10.0K | $31.36 | $314K | 591.5Kdirect | Mar 22, 2016 | Mar 23, 2016 | Form 4 ↗ |
| POPS RICHARD FDirector and CEO, Alkermes plc · Director | Sale | −25.0K | $31.40 | $785K | 576.5Kdirect | Mar 15, 2016 | Mar 16, 2016 | Form 4 ↗ |
| MITCHELL PAUL JDirector | Sale | −2,000 | $32.80 | $66K | 8,000direct | Mar 4, 2016 | Mar 4, 2016 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →